How To Take Apatinib Mesylate Tablets: A Comprehensive Guide
Apatinib mesylate tablets are targeted therapy medications used to treat certain types of cancer, such as advanced gastric cancer, breast cancer, and hepatocellular carcinoma. If you or a loved one has been prescribed this medication, understanding how to take it properly is essential for achieving the best results.
This guide provides detailed instructions and valuable tips for using apatinib mesylate tablets safely and effectively.
What Are Apatinib Mesylate Tablets?
Apatinib mesylate is a tyrosine kinase inhibitor that works by blocking vascular endothelial growth factor receptor-2 (VEGFR-2). By inhibiting VEGFR-2, it restricts the growth of new blood vessels that tumours need to thrive and spread. It is commonly prescribed to patients who have exhausted other treatment options.
How to Take Apatinib Mesylate Tablets
1. Follow Your Doctor’s Prescription
- Always take apatinib mesylate tablets exactly as prescribed by your healthcare provider. The recommended dosage is 850 mg once daily. Do not adjust the dosage or frequency without consulting your doctor.
2. Take It at the Same Time Each Day
- Consistency is key. Take the tablet at the same time every day to maintain stable levels of the medication in your body.
3. Take It With Water
- Swallow the tablet whole with a glass of warm water. Do not crush, chew, or break the tablet unless instructed by your doctor.
4. Take It After Meals
- To minimize potential side effects, take the medication 30 minutes after a meal. Ensure that you maintain a consistent schedule for taking your medication daily.
5. Avoid Certain Foods and Beverages
- Refrain from consuming grapefruit or grapefruit juice, as it may interact with the medication and affect its efficacy. If you miss a dose, do not take extra tablets to make up for it.
Important Safety Tips
- Monitor for Side Effects: Common side effects of apatinib include hypertension, proteinuria, fatigue, and hand-foot syndrome. Report any unusual or severe symptoms to your doctor immediately.
- Avoid Alcohol: Drinking alcohol may worsen side effects or interfere with the medication’s effectiveness.
- Keep Up With Regular Checkups: Frequent monitoring of blood pressure, liver function, and other parameters is essential while taking apatinib.
- Store the Medication Properly: Keep the tablets in a cool, dry place, away from direct sunlight, and out of reach of children.
Tips for Managing Apatinib Mesylate Tablets Side Effects
- Hypertension: Monitor your blood pressure regularly and inform your doctor if it becomes elevated.
- Hand-Foot Syndrome: Use moisturizers and avoid excessive friction or heat exposure to your hands and feet.
- Nausea or Fatigue: Eat small, frequent meals and prioritize rest to manage these symptoms effectively.
When to Contact Your Doctor
- If you miss a dose, consult your doctor rather than taking a double dose.
- If you experience severe side effects such as persistent bleeding, severe abdominal pain, or difficulty breathing, seek immediate medical attention.
Note
This guide is for informational purposes only from DengYueMed and does not substitute professional medical advice.
Always consult your healthcare provider for personalized guidance on using apatinib mesylate tablets. Proper adherence to your prescribed regimen, coupled with regular monitoring, can help optimize treatment outcomes.
Frequently Asked Questions
Q: What Type Of Drug Is Apatinib?
A: Apatinib is a VEGFR-2 tyrosine kinase inhibitor that blocks tumour blood vessel growth.
Q: Are There Any Medications That Interact With Apatinib?
A: Yes, medications that affect liver enzymes (e.g., CYP inhibitors or inducers), anticoagulants, and drugs that alter blood pressure may interact with apatinib. Always consult your doctor for guidance.
Q: What Is The Chinese Name For Apatinib?
A: The Chinese name for apatinib is 阿帕替尼 (Ā pà tì ní).
Q: What Is The Brand Name Of Apatinib?
A: The brand name of apatinib is Aitan. It is manufactured by Hengrui Medicine in China.
Q: Is Apatinib Approved By The FDA?
A: On June 19, 2017, the U.S. FDA granted orphan drug designation to apatinib for the treatment of gastric cancer, recognizing its potential in treating this rare disease.
Related Blogs
- Chinese Innovative Drugs Surge Ahead: Fosun Pharma’s License-Out Deals Exceed USD 60 Billion
- Breaking free from pharmaceutical tariffs! Can innovative drugs accelerate overseas expansion by 2025?
- Top 10 China Pharma Deals 2025: $40B in Global Innovation Exports
- The Fda Anticipates Approving Five New Drugs By October 2025
- Is Melanoma Cancer Curable? 5 Powerful Facts for Hopeful Recovery
